• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Wnt/β-catenin 激活与 p53 缺失协同作用导致小鼠肾上腺皮质癌。

Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.

机构信息

Division of Endocrinology, Boston Children's Hospital, Boston, MA, 02115, USA.

Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA.

出版信息

Oncogene. 2020 Jul;39(30):5282-5291. doi: 10.1038/s41388-020-1358-5. Epub 2020 Jun 19.

DOI:10.1038/s41388-020-1358-5
PMID:32561853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7378041/
Abstract

Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with limited therapeutic options. The lack of mouse models that recapitulate the genetics of ACC has hampered progress in the field. We analyzed The Cancer Genome Atlas (TCGA) dataset for ACC and found that patients harboring alterations in both p53/Rb and Wnt/β-catenin signaling pathways show a worse prognosis compared with patients that harbored alterations in only one. To model this, we utilized the Cyp11b2(AS) mouse line to generate mice with adrenocortical-specific Wnt/β-catenin activation, Trp53 deletion, or the combination of both. Mice with targeted Wnt/β-catenin activation or Trp53 deletion showed no changes associated with tumor formation. In contrast, alterations in both pathways led to ACC with pulmonary metastases. Similar to ACCs in humans, these tumors produced increased levels of corticosterone and aldosterone and showed a high proliferation index. Gene expression analysis revealed that mouse tumors exhibited downregulation of Star and Cyp11b1 and upregulation of Ezh2, similar to ACC patients with a poor prognosis. Altogether, these data show that altering both Wnt/β-catenin and p53/Rb signaling is sufficient to drive ACC in mouse. This autochthonous model of ACC represents a new tool to investigate the biology of ACC and to identify new treatment strategies.

摘要

肾上腺皮质癌(ACC)是一种罕见且侵袭性强的恶性肿瘤,治疗选择有限。缺乏能够重现 ACC 遗传学的小鼠模型,阻碍了该领域的进展。我们分析了癌症基因组图谱(TCGA)数据库中的 ACC 数据,发现同时存在 p53/Rb 和 Wnt/β-catenin 信号通路改变的患者比仅存在一种改变的患者预后更差。为了模拟这种情况,我们利用 Cyp11b2(AS) 小鼠系产生了肾上腺皮质特异性 Wnt/β-catenin 激活、Trp53 缺失或两者组合的小鼠。靶向 Wnt/β-catenin 激活或 Trp53 缺失的小鼠没有与肿瘤形成相关的变化。相比之下,两条通路的改变导致了具有肺转移的 ACC。与人类的 ACC 相似,这些肿瘤产生了增加的皮质酮和醛固酮水平,并显示出高增殖指数。基因表达分析显示,与预后不良的 ACC 患者一样,小鼠肿瘤表现出 Star 和 Cyp11b1 的下调和 Ezh2 的上调。总的来说,这些数据表明改变 Wnt/β-catenin 和 p53/Rb 信号足以在小鼠中驱动 ACC 的发生。这种原发性 ACC 模型代表了一种新的工具,可以研究 ACC 的生物学并确定新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/de07a4e5ebc7/41388_2020_1358_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/2c71034158a5/41388_2020_1358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/eb7f0aff9da1/41388_2020_1358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/139c5fd2429f/41388_2020_1358_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/de07a4e5ebc7/41388_2020_1358_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/2c71034158a5/41388_2020_1358_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/eb7f0aff9da1/41388_2020_1358_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/139c5fd2429f/41388_2020_1358_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a56/7378041/de07a4e5ebc7/41388_2020_1358_Fig4_HTML.jpg

相似文献

1
Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.Wnt/β-catenin 激活与 p53 缺失协同作用导致小鼠肾上腺皮质癌。
Oncogene. 2020 Jul;39(30):5282-5291. doi: 10.1038/s41388-020-1358-5. Epub 2020 Jun 19.
2
BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.BCL9 在肾上腺皮质癌中的上调:一种新型的 Wnt/β-连环蛋白激活事件驱动肾上腺皮质恶性肿瘤。
J Am Coll Surg. 2018 Jun;226(6):988-995. doi: 10.1016/j.jamcollsurg.2018.01.051. Epub 2018 Feb 8.
3
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.肾上腺皮质肿瘤中N-钙黏蛋白/β-连环蛋白表达的研究
Tumour Biol. 2016 Oct;37(10):13545-13555. doi: 10.1007/s13277-016-5257-x. Epub 2016 Jul 28.
4
P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.P53/Rb 抑制诱导临床前转基因模型中的转移性肾上腺皮质癌。
Oncogene. 2017 Aug;36(31):4445-4456. doi: 10.1038/onc.2017.54. Epub 2017 Apr 3.
5
Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.转录组分析显示,一组侵袭性肾上腺皮质癌中存在 p53 和 {β}-连环蛋白的改变。
Cancer Res. 2010 Nov 1;70(21):8276-81. doi: 10.1158/0008-5472.CAN-10-2014. Epub 2010 Oct 19.
6
Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.鉴定携带β-连环蛋白(CTNNB1)突变的肾上腺皮质肿瘤中的差异基因表达。
J Clin Endocrinol Metab. 2011 Jul;96(7):E1206-11. doi: 10.1210/jc.2010-2143. Epub 2011 May 11.
7
Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.沉默突变型β-catenin 抑制肾上腺皮质癌细胞系 H295R 的细胞增殖并刺激细胞凋亡。
PLoS One. 2013;8(2):e55743. doi: 10.1371/journal.pone.0055743. Epub 2013 Feb 7.
8
Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.大规模基因芯片筛查揭示了 RB1 改变在侵袭性肾上腺皮质癌中的作用。
Eur J Endocrinol. 2014 Feb 4;170(3):385-91. doi: 10.1530/EJE-13-0778. Print 2014 Mar.
9
Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/β-catenin signaling pathway and the epithelial-mesenchymal transition process.沉默 MED27 通过靶向 Wnt/β-连环蛋白信号通路和上皮-间充质转化过程抑制肾上腺皮质癌发生。
Biol Chem. 2018 May 24;399(6):593-602. doi: 10.1515/hsz-2017-0304.
10
Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.肾上腺皮质干细胞和祖细胞:对肾上腺皮质癌的影响。
Mol Cell Endocrinol. 2012 Mar 31;351(1):2-11. doi: 10.1016/j.mce.2011.12.006. Epub 2012 Jan 13.

引用本文的文献

1
Spanish consensus on the diagnosis and management of adrenocortical carcinoma.西班牙肾上腺皮质癌诊断与管理共识
Endocr Relat Cancer. 2025 Apr 24;32(5). doi: 10.1530/ERC-25-0034. Print 2025 May 1.
2
Therapeutic strategies for adrenocortical carcinoma: integrating genomic insights, molecular targeting, and immunotherapy.肾上腺皮质癌的治疗策略:整合基因组学见解、分子靶向治疗和免疫治疗
Front Immunol. 2025 Mar 12;16:1545012. doi: 10.3389/fimmu.2025.1545012. eCollection 2025.
3
Adrenocortical stem cells in health and disease.健康与疾病状态下的肾上腺皮质干细胞

本文引用的文献

1
Beta-Catenin Causes Adrenal Hyperplasia by Blocking Zonal Transdifferentiation.β-连环蛋白通过阻断区域转分化引起肾上腺增生。
Cell Rep. 2020 Apr 21;31(3):107524. doi: 10.1016/j.celrep.2020.107524.
2
New strategies for applying targeted therapies to adrenocortical carcinoma.将靶向治疗应用于肾上腺皮质癌的新策略。
Curr Opin Endocr Metab Res. 2019 Oct;8:72-79. doi: 10.1016/j.coemr.2019.07.006. Epub 2019 Aug 6.
3
β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis.β-连环蛋白和 FGFR2 调节出生后基于玫瑰花结的肾上腺皮质形态发生。
Nat Rev Endocrinol. 2025 Mar 10. doi: 10.1038/s41574-025-01091-2.
4
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.Dlk1是一种新型的肾上腺皮质干/祖细胞标志物,可预测肾上腺皮质癌的恶性程度。
Cancer Commun (Lond). 2025 Jun;45(6):663-668. doi: 10.1002/cac2.70012. Epub 2025 Mar 4.
5
Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model.长爪沙鼠可作为原发性醛固酮增多症的自发性啮齿动物模型。
PLoS One. 2025 Feb 13;20(2):e0314943. doi: 10.1371/journal.pone.0314943. eCollection 2025.
6
Competitive signaling and cellular communications in myocardial infarction response.心肌梗死反应中的竞争性信号传导与细胞通讯
Mol Biol Rep. 2025 Jan 16;52(1):129. doi: 10.1007/s11033-025-10236-5.
7
Identification of CENPM as a key gene driving adrenocortical carcinoma metastasis via physical interaction with immune checkpoint ligand FGL1.通过与免疫检查点配体FGL1的物理相互作用鉴定CENPM为驱动肾上腺皮质癌转移的关键基因。
Clin Transl Med. 2025 Jan;15(1):e70182. doi: 10.1002/ctm2.70182.
8
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.Dlk1是一种新型的肾上腺皮质干/祖细胞标志物,可预测肾上腺皮质癌的恶性程度。
bioRxiv. 2024 Aug 22:2024.08.22.609117. doi: 10.1101/2024.08.22.609117.
9
Non-canonical Wnt signaling triggered by WNT2B drives adrenal aldosterone production.由WNT2B触发的非经典Wnt信号传导驱动肾上腺醛固酮的产生。
bioRxiv. 2024 Aug 24:2024.08.23.609423. doi: 10.1101/2024.08.23.609423.
10
Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.肾上腺皮质癌的药物基因组学分析揭示了与米托坦敏感性相关的遗传特征和潜在治疗靶点。
Front Endocrinol (Lausanne). 2024 May 8;15:1365321. doi: 10.3389/fendo.2024.1365321. eCollection 2024.
Nat Commun. 2020 Apr 3;11(1):1680. doi: 10.1038/s41467-020-15332-7.
4
A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis.ZNRF3 依赖性 Wnt/β-catenin 信号梯度对于肾上腺稳态是必需的。
Genes Dev. 2019 Feb 1;33(3-4):209-220. doi: 10.1101/gad.317412.118. Epub 2019 Jan 28.
5
Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism.原发性醛固酮增多症或高肾素性醛固酮增多症的肾上腺皮质癌中的体细胞突变。
Endocr Relat Cancer. 2019 Feb;26(2):217-225. doi: 10.1530/ERC-18-0385.
6
Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era.基因组学时代肾上腺皮质癌的治疗靶点
J Endocr Soc. 2018 Sep 26;2(11):1259-1274. doi: 10.1210/js.2018-00197. eCollection 2018 Nov 1.
7
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.欧洲内分泌学会成人肾上腺皮质癌管理临床实践指南,与欧洲肾上腺肿瘤研究网络合作。
Eur J Endocrinol. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608.
8
Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.肾上腺皮质癌的靶向分子分析:改善个体化预后的策略。
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4511-4523. doi: 10.1210/jc.2018-01348.
9
Mouse Homolog of the Human R337H Mutation Reveals Its Role in Tumorigenesis.鼠源 R337H 突变人源同源基因揭示其在肿瘤发生中的作用。
Cancer Res. 2018 Sep 15;78(18):5375-5383. doi: 10.1158/0008-5472.CAN-18-0016. Epub 2018 Jul 24.
10
MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma.内分泌学机制:肾上腺皮质癌中的细胞周期调控。
Eur J Endocrinol. 2018 Aug;179(2):R95-R110. doi: 10.1530/EJE-17-0976. Epub 2018 May 17.